BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19158275)

  • 1. Protein kinase C-dependent phosphorylation regulates the cell cycle-inhibitory function of the p73 carboxy terminus transactivation domain.
    Nyman U; Vlachos P; Cascante A; Hermanson O; Zhivotovsky B; Joseph B
    Mol Cell Biol; 2009 Apr; 29(7):1814-25. PubMed ID: 19158275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation.
    Burge S; Teufel DP; Townsley FM; Freund SM; Bycroft M; Fersht AR
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3142-7. PubMed ID: 19218448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.
    Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A
    J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1.
    Soond SM; Barry SP; Melino G; Knight RA; Latchman DS; Stephanou A
    Cell Cycle; 2008 May; 7(9):1214-23. PubMed ID: 18418051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p73 by Hck through kinase-dependent and independent mechanisms.
    Paliwal P; Radha V; Swarup G
    BMC Mol Biol; 2007 May; 8():45. PubMed ID: 17535448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73.
    Zdzalik M; Pustelny K; Kedracka-Krok S; Huben K; Pecak A; Wladyka B; Jankowski S; Dubin A; Potempa J; Dubin G
    Cell Cycle; 2010 Nov; 9(22):4584-91. PubMed ID: 21088494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.
    Ethayathulla AS; Tse PW; Monti P; Nguyen S; Inga A; Fronza G; Viadiu H
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6066-71. PubMed ID: 22474346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation.
    Koida N; Ozaki T; Yamamoto H; Ono S; Koda T; Ando K; Okoshi R; Kamijo T; Omura K; Nakagawara A
    J Biol Chem; 2008 Mar; 283(13):8555-63. PubMed ID: 18174154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity.
    Sauer M; Bretz AC; Beinoraviciute-Kellner R; Beitzinger M; Burek C; Rosenwald A; Harms GS; Stiewe T
    Nucleic Acids Res; 2008 Apr; 36(6):1900-12. PubMed ID: 18267967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function.
    Wu H; Leng RP
    Oncotarget; 2015 Aug; 6(25):21479-92. PubMed ID: 26025930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis.
    Tozluoğlu M; Karaca E; Haliloglu T; Nussinov R
    Nucleic Acids Res; 2008 Sep; 36(15):5033-49. PubMed ID: 18660513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity.
    Zhang L; Nie L; Maki CG
    Mol Cancer; 2006 Dec; 5():68. PubMed ID: 17150106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-terminal sterile alpha motif and the extreme C terminus regulate the transcriptional activity of the alpha isoform of p73.
    Liu G; Chen X
    J Biol Chem; 2005 May; 280(20):20111-9. PubMed ID: 15769743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the transactivation domains of p53 family members: a computational study.
    Mavinahalli JN; Madhumalar A; Beuerman RW; Lane DP; Verma C
    BMC Genomics; 2010 Feb; 11 Suppl 1(Suppl 1):S5. PubMed ID: 20158876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p73 supports cellular growth through c-Jun-dependent AP-1 transactivation.
    Vikhanskaya F; Toh WH; Dulloo I; Wu Q; Boominathan L; Ng HH; Vousden KH; Sabapathy K
    Nat Cell Biol; 2007 Jun; 9(6):698-705. PubMed ID: 17496887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E1A activates transcription of p73 and Noxa to induce apoptosis.
    Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M
    J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
    Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
    J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53.
    Grob TJ; Novak U; Maisse C; Barcaroli D; Lüthi AU; Pirnia F; Hügli B; Graber HU; De Laurenzi V; Fey MF; Melino G; Tobler A
    Cell Death Differ; 2001 Dec; 8(12):1213-23. PubMed ID: 11753569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73.
    van Dieck J; Brandt T; Teufel DP; Veprintsev DB; Joerger AC; Fersht AR
    Oncogene; 2010 Apr; 29(14):2024-35. PubMed ID: 20140014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of p73 functional domains necessary for transactivation and growth suppression.
    Nozell S; Wu Y; McNaughton K; Liu G; Willis A; Paik JC; Chen X
    Oncogene; 2003 Jul; 22(28):4333-47. PubMed ID: 12853970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.